Defibrillators Market Report by Product Type, End-User, and Region 2024-2032

The global defibrillators market size reached US$ 5.4 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 9.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.84% during 2023-2032. The increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, rising number of public access locations, and the growing number of ambulance services are some of the major factors propelling the market.

Defibrillators are medical devices designed to restore a normal heartbeat by delivering an electrical shock to the heart. They are designed to be user friendly to ensure that people without medical training can also operate them in emergency situations. They are crucial in emergency situations involving cardiac arrest, which is a condition wherein the heart suddenly stops beating effectively. They provide an electrical shock that can jolt the heart back into a normal rhythm, which potentially saves the life of an individual. They are commonly used in hospitals, ambulances, and public places like airports and shopping malls.

Increasing incidence of heart diseases, such as coronary artery disease and arrhythmias, is driving the demand for defibrillators around the world. Moreover, the rising number of public access locations, including malls, parks, and transportation hubs, is favoring the growth of the market. In addition, the growing number of ambulance services that are equipped with defibrillators in vehicles to enhance emergency medical care during transit is influencing the market positively. Apart from this, the expansion of the sports and fitness industry is increasing the adoption of defibrillators in gyms, sports facilities, and recreational areas. Furthermore, the surging prevalence of obesity, which is correlated with a higher risk of cardiac issues, is bolstering the market growth.

Defibrillators Market Trends/Drivers:

Increasing awareness about cardiac health

The demand for defibrillators is on a rise due to the increasing awareness about cardiac health among the masses. Individuals and organizations are becoming more cognizant of the risks associated with sudden cardiac arrest (SCA), which can strike anyone, anywhere. This heightened awareness has led to a proactive approach in preparedness. Schools, offices, public spaces, and even households are recognizing the importance of having defibrillators readily available. The potential to save lives in critical moments has driven the demand. Moreover, educational campaigns and training initiatives have demystified the use of defibrillators, making them more accessible and user-friendly.

Rise in aging population and chronic diseases

The aging population worldwide is another significant factor catalyzing the demand for defibrillators. As people age, the risk of cardiac-related issues increases. Moreover, the surging prevalence of chronic diseases, such as hypertension and diabetes has also risen. These conditions can lead to heart problems, which makes defibrillators a crucial medical device for emergency response. Healthcare facilities, senior living communities, and home care providers are all investing in defibrillators to ensure timely intervention in case of cardiac emergencies. This demographic shift is expected to sustain and further catalyzing the demand for defibrillators.

Growing legislation and regulatory mandates

Regulatory mandates and legislation have played a pivotal role in driving the demand for defibrillators. Many countries and regions have implemented laws requiring specific locations, such as airports, sports stadiums, and public buildings, to have automated external defibrillators (AEDs) readily available. This legal framework has created a compelling need for organizations to comply with these requirements, thus leading to increased procurement of defibrillators. Additionally, industries with high occupational health and safety standards like construction and manufacturing are investing in defibrillators to ensure compliance and enhance workplace safety. The convergence of legislation and safety regulations has made defibrillators an indispensable component of emergency response infrastructure.

Defibrillators Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, and end-user.

Breakup by Product Type:

• Implantable Defibrillators
• Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
• Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
• Cardiac Resynchronization Therapy Defibrillator (CRT-D)
• External Defibrillators
• Manual External Defibrillator
• Automated External Defibrillator (AEDs)
• Wearable Cardioverter Defibrillator (WCDs)

Automated external defibrillator (AEDs) dominate the market

T-ICDs are inserted into the body via a vein, typically in the upper chest area. They are connected to the heart through leads placed inside the veins. The device continually monitors the rhythm of the heart and automatically administers an electrical shock when it detects dangerous arrhythmias. T-ICDs are commonly used in patients who have had previous episodes of sudden cardiac arrest or are at high risk for it.

Breakup by End-User:

• Hospitals and Clinics
• Prehospital Care Settings
• Cardiac Centers
• Homecare Settings
• Others

Hospitals and clinics hold the largest share in the market

Prehospital care settings refer to emergency medical services that are administered before a patient arrives at a hospital. This can include care given by paramedics in ambulances or first responders at the scene of a medical emergency. In these settings, AEDs or portable manual external defibrillators are commonly used. AEDs are especially useful in this context because they can be operated by a broader range of medical personnel and even by bystanders under guidance, allowing for more immediate intervention. Prehospital care providers often receive specialized training in cardiac life support, which includes the effective use of defibrillators.

Breakup by Region:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest defibrillators market share

The surging prevalence of cardiovascular-related health issues represents one of the primary factors driving the demand for defibrillators in the North America region. Moreover, the rising public awareness about the risks of sudden cardiac arrest is favoring the growth of the market in the region. Besides this, a well-established healthcare facilities are influencing the market positively in the region.

Asia Pacific is estimated to witness stable growth, owing to ongoing research and development (R&D) projects, government initiatives, integration of advanced technologies, etc.

Competitive Landscape:

The leading companies are developing advanced defibrillators that are equipped with real time monitoring and feedback mechanisms to provide instant analysis of a heart rhythm of a patient and offer guidance to the operator, which improves the chances of successful defibrillation. Moreover, key players are introducing defibrillators integrated with touch screen technology, voice-guided prompts, and visual aids to reduce the time it takes to administer life-saving treatment. They are also adopting the usage of wireless connectivity that allows for remote monitoring and data analysis and enables healthcare providers to keep track of device performance and patient data seamlessly, which can be invaluable for post-care assessment and ongoing treatment planning.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• Asahi Kasei Zoll Medical Corporation
• Biotronik
• Boston Scientific Corporation
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic Inc.
• Nihon Kohden Corporation
• Schiller AG
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• Stryker Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

• In 2020, Koninklijke Philips N.V. announced that its Emergency Care and Resuscitation (ECR) business recommenced the US manufacturing and shipping of external defibrillators.
• In 2022, Medtronic Inc. declared that its investigational EV ICD™ System - a first-of-its-kind defibrillator with the lead placed under the breastbone, outside of the heart and veins - achieved a defibrillation success rate of 98.7% and met its safety endpoints in a global clinical trial.
• In July 2021, Asahi Kasei Zoll Medical Corporation stated that it has received FDA 510(k) clearance to release the TBI Dashboard™ feature on its Propaq® M monitor and Propaq MD monitor/defibrillator.

Key Questions Answered in This Report:

• How has the global defibrillators market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global defibrillators market?
• What is the impact of each driver, restraint, and opportunity on the global defibrillators market?
• What are the key regional markets?
• Which countries represent the most attractive defibrillators market?
• What is the breakup of the market based on the product type?
• Which is the most attractive product type in the defibrillators market?
• What is the breakup of the market based on the end-user?
• Which is the most attractive end-user in the defibrillators market?
• What is the competitive structure of the global defibrillators market?
• Who are the key players/companies in the global defibrillators market?